27 results on '"Pujol, J"'
Search Results
2. Efficacy and safety of maintenance pemetrexed in patients with advanced nonsquamous non-small cell lung cancer following pemetrexed plus cisplatin induction treatment: A cross-trial comparison of two phase III trials
3. PD-073 A new simplified comorbidity score as prognostic factor innon-small cell lung cancer (NSCLC) Patients: Description and comparison with the Charlson's index
4. PD-079 Should chemotherapy combinations for advanced non-small cell lung cancer (NSCLC) be platinum-based? A literature-based meta-analysis of phase III randomised trials
5. O-159 A prospective randomized phase III, double-blind, placebo-controlled study of thalidomide in extended-disease (ED) SCLC patients after response to chemotherapy (CT)
6. Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes
7. Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer
8. Reply to Dr J Watine
9. Etoposide-cisplatin (EP) versus four-drug combination etoposide-cisplatin-epirubicin-cyclophosphamide (PCDE) in extensive disease small cell lung cancer (ED-SCLC). A FNCLCC phase III multicentre study
10. Patterns of relapse of clinical N2 non-small-cell lung cancer (NSCLC) treated with preoperative chemotherapy: Should propylactic cranial irradiation be reconsidered?
11. A phase I–II study of docetaxel (D) and gemcitabine (G) combination in patients (pts) with non-small cell lung cancer (NSCLC)
12. Smoking cessation duration: Evaluation of prognostic determinants
13. Concomitant brain radiotherapy and vinorelbine–ifosfamide–cisplatin chemotherapy in brain metastases of non-small cell lung cancer
14. 593 Are pretreatment tumour marker serum levels useful in predicting tumour response during non-small cell lung cancer (NSCLC) chemotherapy?
15. 621 Markov model of small cell lung cancer (SCLC): Assessing the influence of serial determination of serum NSE on prognosis
16. Phase II study of alternating combination chemotherapy in small cell lung cancer
17. Dose-finding, pharmacokinetic and phase II study of docetaxel in combination with gemcitabine in patients with inoperable non-small cell lung cancer
18. Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practice
19. Pro-gastrin-releasing peptide, neuron specific enolase and chromogranin A as serum markers of small cell lung cancer
20. r-metHuG-CSF support to ifosfamide, cisplatin, etoposide chemotherapy in non-zmall cell lung cancer
21. Preliminary results of a randomized study comparing the efficacy of 2 doses of docetaxel 100 mg/m2/3 weeks vs 75 mg/m2/3 weeks in treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) after failure of a previous cis-platin based chemotherapy
22. Phase II study of Topotecan (T) IV with carboplatin (Carbo) in advanced NSCLC
23. NSE and prognosis of non-small-cell lung cancer with synchronous brain metastases: Second analysis
24. Interleukin-1a and soluble interleukin-2 receptor during small cell lung cancer chemotherapy: comparison of high chemotherapy dose with rhGM-CSF and standard chemotherapy dose without rhGM-CSF
25. Neoadjuvant chemotherapy of locally advanced non-small cell lung cancer
26. Detection of lymph node metastases in lung cancer: comparison of ^1^3^1I-Anti-CEA-Anti-CA 19-9 immunoscintigraphy versus computed tomography
27. Combined treatment modalities in non-small cell lung cancer: a French experience
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.